Daily Archives: February 25, 2020
TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice
The authors identified a metabolite produced by intestinal bacteria, TMAVA, that worsens fatty liver disease by reducing production of the amino acid carnitine. Carnitine might therefore be used for treatment of fatty liver. Continue reading
Pre-treatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients with Inflammatory Bowel Diseases
Frail patients with IBD have an increased risk of infection after anti-TNF or immunomodulator therapy. Continue reading
VUMC Infection Prevention continues to monitor coronavirus situation
As the 2019 Novel Coronavirus (SARS-CoV-2 which causes COVID-19) continues to spread, with new cases reported in, among other places, Northern Italy, Iran, Japan, and South Korea, VUMC continues to monitor the outbreak closely. Starting today, the trav… Continue reading
Five things for employees to know about the COVID-19 coronavirus; five things about coronavirus to tell our patients
While there are currently no individuals in Tennessee who have tested positive for the COVID-19 virus, plans are being finalized that would help manage an influx of patients into our clinics and hospitals. Continue reading